Literature DB >> 12736803

Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome.

Hirohiko Hohjoh1, Miwa Takasu, Kaori Shishikura, Yasurou Takahashi, Yutaka Honda, Katsushi Tokunaga.   

Abstract

Arylalkylamine N-acetyltransferase (AA-NAT) is a rate-limiting enzyme in melatonin hormone synthesis and participates in daily oscillations of the melatonin level. We studied the association between the AA-NAT gene and delayed sleep phase syndrome (DSPS). Results indicate that there is a significant difference in allele positivity at the single nucleotide polymorphism involved in an amino acid substitution from alanine to threonine at position 129 between patients with DSPS and healthy controls. The frequency of the 129 threonine allele is significantly higher in the patients than in the controls ( P=0.0029). The data suggest that AA-NAT could be a susceptibility gene for DSPS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12736803     DOI: 10.1007/s10048-002-0141-9

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  17 in total

1.  Novel polymorphism of AA-NAT gene in Indian goat breeds differing in reproductive traits.

Authors:  R Sharma; S Ahlawat; M S Tantia
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

2.  Circadian rhythm sleep disorders.

Authors:  Lirong Zhu; Phyllis C Zee
Journal:  Neurol Clin       Date:  2012-11       Impact factor: 3.806

3.  Search for informative polymorphisms in candidate genes: clock genes and circadian behaviour in blue tits.

Authors:  C Steinmeyer; J C Mueller; B Kempenaers
Journal:  Genetica       Date:  2008-09-16       Impact factor: 1.082

4.  Sleep timing and circadian phase in delayed sleep phase syndrome.

Authors:  Anne-Marie Chang; Kathryn J Reid; Ramadevi Gourineni; Phyllis C Zee
Journal:  J Biol Rhythms       Date:  2009-08       Impact factor: 3.182

Review 5.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Systematic evaluation of Axis-I DSM diagnoses in delayed sleep phase disorder and evening-type circadian preference.

Authors:  Kathryn J Reid; Ashley A Jaksa; Julie B Eisengart; Kelly G Baron; Brandon Lu; Peter Kane; Joseph Kang; Phyllis C Zee
Journal:  Sleep Med       Date:  2012-08-19       Impact factor: 3.492

Review 7.  A clinical approach to circadian rhythm sleep disorders.

Authors:  Ana Barion; Phyllis C Zee
Journal:  Sleep Med       Date:  2007-03-28       Impact factor: 3.492

8.  Testing for associations between candidate genes for circadian rhythms and individual variation in sleep behaviour in blue tits.

Authors:  C Steinmeyer; B Kempenaers; J C Mueller
Journal:  Genetica       Date:  2012-08-26       Impact factor: 1.082

Review 9.  Neurobiology of circadian rhythm sleep disorders.

Authors:  Prasanth Manthena; Phyllis C Zee
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

10.  Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial.

Authors:  Jeanne M McCaffery; George D Papandonatos; Gordon S Huggins; Inga Peter; Bahar Erar; Steven E Kahn; William C Knowler; Edward W Lipkin; Abbas E Kitabchi; Lynne E Wagenknecht; Rena R Wing
Journal:  Hum Hered       Date:  2013-09-27       Impact factor: 0.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.